Progesterone and is responsible for approximately 70% of cytochrome P450-mediated progesterone metabolism. Other routes include 6α-, 16α-, and 16β-hydroxylation. However, treatment of women with ketoconazole, a strong CYP3A4 inhibitor, had minimal effects on progesterone levels, producing only a slight and non-significant increase, and this suggests that cytochrome P450 enzymes play only a small role in progesterone metabolism. In women, progesterone levels are relatively low during the preovulatory phase of the menstrual cycle, rise after ovulation, and are elevated during the luteal phase, as shown in diagram below. Progesterone levels tend to be less than 2 ng/mL prior to ovulation, and greater
Menstrual synchrony of the thawed axillary pad under their noses daily. The researchers concluded that odorless compounds collected from women during the late follicular phase of their menstrual cycles triggered hormonal events that shortened the menstrual cycles of the recipient women, and that odorless compounds collected from women during the time of ovulation triggered a hormonal event in the recipient women that lengthened their menstrual cycles. Stern and McClintock concluded that these findings "proved the existence of human pheromones" as well as illustrated manipulation of the human menstrual cycle. Researchers pointed out several flaws in their study. Whitten's main critiques was with